Prochlorperazine vs Imitrex for Acute Migraine in the Emergency Department
Status:
Completed
Trial end date:
2007-05-01
Target enrollment:
Participant gender:
Summary
ED patients with acute migraine will be randomized to either prochlorperazine and Bendaryl OR
imitrex. VAS for pain will be monitored, along with side effects. Primary outcome measure is
improvement in pain scales between the groups.